Announcements

Cambridge’s auryx raises $2M with PurposeTech to turn earbuds into continuous health monitors

by
Jakob Ulrych
April 30, 2026
Cambridge-based deep tech startup auryx has secured $2 million in pre-seed funding to commercialise a platform that turns everyday consumer devices - starting with earbuds - into continuous health monitors using sound. The round was led by UK-based Celero Ventures, with participation from Czech PurposeTech, EWOR, Cambridge Enterprise Ventures, Vento, and a syndicate of additional institutional and angel investors.

Founded by a team of scientists and engineers, auryx builds on a decade of University of Cambridge research at the intersection of machine learning and audio diagnostics. The company’s software analyses acoustic signals from the heart, lungs, and blood flow, allowing microphones already embedded in consumer hardware to capture physiological data in real time – without additional sensors or any change in user behaviour.

The team brings together three complementary strands of research. CEO Erika Bondareva focused on cardiovascular diagnostics from audio signals, while CTO Kayla-Jade Butkow explored how in-ear microphones could be used to measure vital signs. They are joined by Chief Scientific Officer Cecilia Mascolo, Professor of Mobile Systems at the University of Cambridge, who spent more than a decade building the scientific foundation of the field.

"We spent years in research proving that sound carries more health information than anyone had thought to listen for. Auryx exists because we decided it was time to start doing something with this finding beyond the lab. Now we are putting it to work into devices people already wear, making continuous health monitoring something that just happens, without anyone having to think about it."

Most consumer health wearables today rely on optical sensors at the wrist, where motion artefacts limit accuracy. The ear is more stable during everyday activity, and because auryx’s approach is acoustic rather than optical, it can extract a far broader range of physiological signals — including respiratory rate, cardiac output, and blood pressure, in addition to heart rate. The company is initially targeting the global earbud market, with plans to expand to other microphone-equipped devices and health applications over time.

"The founders are among the most qualified people in the world working on health sensing, with a proprietary knowledge base and more than a five-year head start over anyone else attempting this. We believe they are uniquely positioned to build breakthrough software that will transform how health data is collected and evaluated in everyday life and to establish themselves as the global category leader."

Subscribe to our newsletter

Join our newsletter to get the best hottest startup tapas.

Popular posts

US-based Flick Raises $6M Seed Round from global investors including Czech N1

May 18, 2026

Czech VC fund Tech Horizons invests in Canadian startup North Vector Dynamics focusing on stoping drones without firing expensive missiles

May 14, 2026

Brno-based JIC Ventures’ joins FaceUp’s Series A as their first Fund investment 

May 19, 2026

Related posts

Viktor, a Warsaw and Munich-based AI startup that develops an AI coworker that lives in Slack and Microsoft Teams and works across the tools companies already use, has raised €64.7 million ($75 million) in Series A funding.
by
Jakob Ulrych
The acquisition comes as Mistral look to position itself as the AI partner for industrial enterprises across Europe.
by
Jakob Ulrych
The European Commission has selected EQT to lead the newly created €5bn Scaleup Europe Fund, handing the Nordic investment giant one of the most strategic mandates in Europe’s startup ecosystem.
by
Tom Cironis
Six weeks after launching its new fund, JIC Ventures has made its first startup investment – in FaceUp, a technology platform that helps companies build an ethical culture and prevent risk. The fund joined a Series A round totalling $5 million, led by Croatian fund Fil Rouge Capital, bringing not only capital but also knowing the company from its very beginnings.
by
Jakob Ulrych